[{"headline": "AzurRx BioPharma shares rise after positive result in test to treat ...", "headline_url": "google.com/url?q=http://www.proactiveinvestors.com/companies/news/205551/azurrx-biopharma-shares-rise-after-positive-result-in-test-to-treat-chronic-pancreatitis-205551.html&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIEygAMAE&usg=AOvVaw1R0DDBqZjfLe1f3aLj2mwO", "source_and_date": "Proactive Investors USA & Canada - \u05dc\u05e4\u05e0\u05d9 5 \u05d9\u05de\u05d9\u05dd", "content": "AzurRx BioPharma Inc (NASDAQ:AZRX) stock climbed on Monday after announcing along with European pharma company Mayoly Spindler\u00a0..."}, {"headline": "Zacks: AzurRx BioPharma Inc (AZRX) Receives Consensus Rating ...", "headline_url": "google.com/url?q=https://www.mareainformativa.com/2018/09/28/zacks-azurrx-biopharma-inc-azrx-receives-consensus-rating-of-strong-buy-from-analysts-updated-updated-updated-updated.html&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIGSgAMAI&usg=AOvVaw3-rqMBsUpCMmSoi70aJWmK", "source_and_date": "Marea Informative (blog) - \u05dc\u05e4\u05e0\u05d9 20 \u05e9\u05e2\u05d5\u05ea", "content": "AzurRx BioPharma Inc (NASDAQ:AZRX) has received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover\u00a0..."}, {"headline": "AzurRx BioPharma, Inc. (AZRX) crosses 6.31% over SMA-50", "headline_url": "google.com/url?q=https://nasdaqplace.com/2018/09/28/azurrx-biopharma-inc-azrx-crosses-6-31-over-sma-50/&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIGygAMAM&usg=AOvVaw362SM5jFoqz6XUPGps9gNz", "source_and_date": "Nasdaq Place (press release) - \u05dc\u05e4\u05e0\u05d9 \u05d9\u05d5\u05dd 1", "content": "AzurRx BioPharma, Inc. (AZRX) recently closed with rise of 0.21% to its 20-Day Simple Moving Average. This short time frame picture\u00a0..."}, {"headline": "Zacks: Analysts Expect AzurRx BioPharma Inc (AZRX) Will Post ...", "headline_url": "google.com/url?q=https://www.baseballdailydigest.com/2018/09/26/zacks-analysts-expect-azurrx-biopharma-inc-azrx-will-post-earnings-of-0-24-per-share.html&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIHigAMAQ&usg=AOvVaw2koM0RikzBA9LRSosCrAG7", "source_and_date": "Baseball Daily News - \u05dc\u05e4\u05e0\u05d9 2 \u05d9\u05de\u05d9\u05dd", "content": "Analysts expect AzurRx BioPharma Inc (NASDAQ:AZRX) to post earnings per share of ($0.24) for the current quarter, according to Zacks\u00a0..."}, {"headline": "The Big Impact Of Technical Data: Fate Therapeutics, Inc. (FATE ...", "headline_url": "google.com/url?q=https://nmsunews.com/2018/09/25/the-big-impact-of-technical-data-fate-therapeutics-inc-fate-azurrx-biopharma-inc-azrx/&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIIygAMAU&usg=AOvVaw1UrLW46sD7fYzJqmhyOCnq", "source_and_date": "NMSU N\u0435ws - \u05dc\u05e4\u05e0\u05d9 4 \u05d9\u05de\u05d9\u05dd", "content": "AzurRx BioPharma, Inc. (NASDAQ:AZRX) added 11.32% to its trading price by the close of the most recent session, jumping from its previous\u00a0..."}, {"headline": "Stock alteration summary:: AzurRx BioPharma, Inc., (NASDAQ: AZRX)", "headline_url": "google.com/url?q=https://topstocksnews.com/2018/09/25/stock-alteration-summary-azurrx-biopharma-inc-nasdaq-azrx/&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIILCgAMAY&usg=AOvVaw0YpqOF15kk3LgNgsblaEEy", "source_and_date": "Top Stocks News (press release) - \u05dc\u05e4\u05e0\u05d9 4 \u05d9\u05de\u05d9\u05dd", "content": "AzurRx BioPharma, Inc., belongs to Healthcare sector and Biotechnology industry. The company's Market capitalization is $46.88M with the\u00a0..."}, {"headline": "Zacks: Analysts Anticipate AzurRx BioPharma Inc (AZRX) to Post ...", "headline_url": "google.com/url?q=https://www.fairfieldcurrent.com/2018/09/27/zacks-analysts-anticipate-azurrx-biopharma-inc-azrx-to-post-0-24-earnings-per-share.html&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIILygAMAc&usg=AOvVaw3hAwHnv7Mv2R_3Toj9X4d2", "source_and_date": "Fairfield Current - \u05dc\u05e4\u05e0\u05d9 2 \u05d9\u05de\u05d9\u05dd", "content": "Wall Street analysts forecast that AzurRx BioPharma Inc (NASDAQ:AZRX) will report earnings of ($0.24) per share for the current quarter,\u00a0..."}, {"headline": "Zacks: AzurRx BioPharma Inc (AZRX) Given $7.83 Average Price ...", "headline_url": "google.com/url?q=https://www.fairfieldcurrent.com/2018/09/23/zacks-azurrx-biopharma-inc-azrx-given-7-83-average-price-target-by-analysts.html&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIMSgAMAg&usg=AOvVaw2BhIWrcz0_mqxARLIzNYUo", "source_and_date": "Fairfield Current - \u05dc\u05e4\u05e0\u05d9 6 \u05d9\u05de\u05d9\u05dd", "content": "AzurRx BioPharma Inc (NASDAQ:AZRX) has received a consensus broker rating score of 1.00 (Strong Buy) from the one analysts that cover\u00a0..."}, {"headline": "AzurRx BioPharma Inc (AZRX) Given Consensus Rating of \u201cStrong ...", "headline_url": "google.com/url?q=https://www.fairfieldcurrent.com/2018/09/26/azurrx-biopharma-inc-azrx-given-consensus-rating-of-strong-buy-by-analysts.html&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIMygAMAk&usg=AOvVaw29HQvsMzvIqO8vtmJpbQr3", "source_and_date": "Fairfield Current - \u05dc\u05e4\u05e0\u05d9 3 \u05d9\u05de\u05d9\u05dd", "content": "Shares of AzurRx BioPharma Inc (NASDAQ:AZRX) have been assigned an average broker rating score of 1.00 (Strong Buy) from the one\u00a0..."}, {"headline": "Should You Follow These Analysts? AzurRx BioPharma, Inc. (AZRX)", "headline_url": "google.com/url?q=https://nasdaqplace.com/2018/09/25/should-you-follow-these-analysts-azurrx-biopharma-inc-azrx/&sa=U&ved=0ahUKEwiXwYi8_uDdAhUKblAKHQAICiQQqQIIOigAMAo&usg=AOvVaw06iY8JAxgE6qa_MQQrTN9N", "source_and_date": "Nasdaq Place (press release) - \u05dc\u05e4\u05e0\u05d9 4 \u05d9\u05de\u05d9\u05dd", "content": "A glance over shares of AzurRx BioPharma, Inc. (AZRX) price that shifted 12.90% away from 20-Days Simple Moving Average, 17.41% from\u00a0..."}]